Download
1-s2.0-S2352385918300252-main.pdf 1,49MB
WeightNameValue
1000 Titel
  • The correction of the metabolic parameters of msg-induced obesity in rats by 2-[4-(benzyloxy) phenoxy] acetic acid
1000 Autor/in
  1. Konopelniuk, Victoria |
  2. Falalyeyeva, Tetyana |
  3. Tsyryuk, Olena |
  4. Savchenko, Yuliia |
  5. Prybytko, Iryna |
  6. Kobyliak, Nazarii |
  7. Kovalchuk, Oleksandr |
  8. Boyko, Aleksandr |
  9. Arkhipov, Viatcheslav V. |
  10. Moroz, Yurii |
  11. Ostapchenko, Liudmyla |
1000 Erscheinungsjahr 2018
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2018-07-18
1000 Erschienen in
1000 Quellenangabe
  • 13:1-9
1000 Copyrightjahr
  • 2018
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.jnim.2018.07.002 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Epidemiological data showed that the number of obese people increases swiftly in all countries. Obesity can evoke metabolic syndrome or second type diabetes (T2D). So, the aim of our study was to investigate the influence of 2-[4-(benzyloxy) phenoxy] acetic acid on metabolic parameters of monosodium glutamate (MSG)-induced obesity in rats. We divided the rats as follows: 1- control group, 2 - MSG-group, 3 - MSG + 2-[4-(benzyloxy) phenoxy] acetic acid group. We investigated anthropometric parameters and blood biochemistry. It was established that MSG induced the development of visceral obesity in rats, in particular, it increased the Lee index, body mass index, deposits of subcutaneous, gonadal and visceral adipose tissue. The administration of 2-[4-(benzyloxy) phenoxy] acetic acid decreased metabolic parameters evoked by MSG. After obesity induction, there was recorded significant growth of cholesterol, triglycerides, and LDL cholesterol blood levels and significant decline in HDL cholesterol blood levels. There was a significant reduction in triglycerides, LDL cholesterol and VLDL, in 2-[4-(benzyloxy) phenoxy] acetic acid - treated group. Our results represent the basis for development of new treatment of obesity and associated conditions.
1000 Sacherschließung
lokal Obesity
lokal acetic acid
lokal Metabolic syndrome
lokal Monosodium glutamate
lokal 2-[4-(benzyloxy) phenoxy] acetic acid
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S29ub3BlbG5pdWssIFZpY3Rvcmlh|https://frl.publisso.de/adhoc/uri/RmFsYWx5ZXlldmEsIFRldHlhbmE=|https://frl.publisso.de/adhoc/uri/VHN5cnl1aywgT2xlbmE=|https://frl.publisso.de/adhoc/uri/U2F2Y2hlbmtvLCBZdWxpaWE=|https://frl.publisso.de/adhoc/uri/UHJ5Ynl0a28sIElyeW5h|https://frl.publisso.de/adhoc/uri/S29ieWxpYWssIE5hemFyaWk=|https://frl.publisso.de/adhoc/uri/S292YWxjaHVrLCBPbGVrc2FuZHI=|https://frl.publisso.de/adhoc/uri/Qm95a28sIEFsZWtzYW5kcg==|https://frl.publisso.de/adhoc/uri/QXJraGlwb3YsIFZpYXRjaGVzbGF2IFYu|https://frl.publisso.de/adhoc/uri/TW9yb3osIFl1cmlp|https://frl.publisso.de/adhoc/uri/T3N0YXBjaGVua28sIExpdWRteWxh
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6416251.rdf
1000 Erstellt am 2019-09-06T13:39:02.767+0200
1000 Erstellt von 218
1000 beschreibt frl:6416251
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet 2019-09-06T13:40:03.949+0200
1000 Objekt bearb. Fri Sep 06 13:39:46 CEST 2019
1000 Vgl. frl:6416251
1000 Oai Id
  1. oai:frl.publisso.de:frl:6416251 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source